Myofascial Pain Syndrome by Dr. Andrea Furlan MD PhD
OverviewPostherpetic neuralgia is the most common complication of shingles. This disorder affects the nerve fibers and skin, causing burning pain and lasting long after the shingles rash and blisters have disappeared.
SymptomsThe signs and symptoms of postherpetic neuralgia are usually confined to the area of skin where the shingles outbreak first occurred, most often in a band around the trunk, usually on one side of the body.
When to see a doctorConsult a doctor at the first sign of shingles. Often, the pain begins before you notice a rash. The risk of developing postherpetic neuralgia is reduced if you start taking antiviral medications within 72 hours after the shingles rash develops.
ComplicationsDepending on how long it lasts and how much pain postherpetic neuralgia causes, people with this disorder may have other symptoms, which are common with chronic pain:
How to Relieve Peripheral Neuropathy Pain? – Dr.Berg
Are you suffering from pain? Do you need a way to relieve your stress, injury, or lack of energy? If so, there is a proven solution for you – our expert chiropractic services in Oakland, by Oakland Pain and Injury Center!
We will recommend a care plan that is unique to you. We provide optimal care for each of our patients. At Oakland Pain and Injury Center we value chiropractic education to our patients to support the relief process.
Our goal is to help you with your wellness needs, improve your quality of life, and help you heal with our services. We proudly serve the Oakland community with our comprehensive chiropractic care and rehabilitation treatment in a friendly and professional environment.
Chiropractic is the largest alternative health care profession in North America and the number three health care profession in the U.S. The muscles and nerves of the body work together to maintain health. When there is an obstacle in the nerve communication stream, tension is created. A chiropractor can find the source of tension in the body, and can restore health and longevity.
Neuralgia postherpética (herpes Zóster)
En el presente estudio, sólo se registró un caso (1/130) de recidiva en el mismo lugar a los 7 meses. No se observaron recidivas (0/130) en sitios diferentes. El 47,6% de los pacientes seguía experimentando dolor al mes de la aparición de la erupción (IC del 95% = 35,6-56,7%), el 14,5% (IC del 95% = 7,8-21,2%) a los 3 meses, el 9,0% (IC del 95% = 3,7-14,3%) a los 6 meses y el 5,9% (IC del 95% = 1,5-10,3%) a los 12 meses (Figura 1). La duración media del dolor fue de 26,5 días (IC del 95% = 20-34). La figura 2 muestra el porcentaje de pacientes con NPH al mes y a los 3 meses en cada grupo de edad. La edad media de los pacientes que cumplían la definición de NPH al mes era de 66,7 años, y el 61,7% de los pacientes eran mujeres. En el caso de la NPH a los 3 meses, la edad media fue de 70,1 años, y el 50% de los pacientes con NPH eran mujeres. El porcentaje de pacientes que desarrollaron NPH (a 1 mes) aumentó con la edad desde el 21,4% (IC 95% = 8,3-40) en los pacientes < 50 años hasta el 59,2% (IC 95% = 44,4-74) en los pacientes ≥ 70 años (Figura 2).Figura 1
Al 91% de los pacientes se les prescribieron antivirales, que representaron el 77% del coste total de la medicación. Otros medicamentos utilizados fueron los anticonvulsivos (12,2%), los analgésicos (4,7%), los antidepresivos (0,6%), los opioides (0,5%) y los corticoides (0,4%), representando en conjunto el 18,4% del coste total de la medicación. Los costes totales y medios por grupos de edad se resumen en la tabla 3.Tabla 3 Coste total* de los pacientes incluidos en el estudio con diagnóstico de herpes zoster por subgrupos de edadTabla completa
HOW TO CURE HERPES ZOSTER shingles
This is an open access article, distributed under the terms of the Creative Commons Attribution-ShareAlike License 4.0 International (http://creativecommons.org/licenses/by-sa/4.0/), which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Minakata T, Inagaki A, Sekiya S, Murakami S. Contrast-enhanced magnetic resonance imaging of facial nerve swelling in patients with severe Ramsay Hunt syndrome. Auris Nasus Larynx. 2019;46(5):687-95.
Monsanto R da C, Bittencourt AG, Bobato Neto NJ, Beilke SCA, Lorenzetti FTM, Salomone R. Treatment and Prognosis of Facial Palsy on Ramsay Hunt Syndrome: Results Based on a Review of the Literature. Int Arch Otorhinolaryngol. 2016/05/30. 2016 Oct;20(4):394-400.
Kim HJ, Jung J, Kim SS, Byun JY, Park MS, Yeo SG. Comparison of Acyclovir and Famciclovir for Ramsay Hunt Syndrome. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc [And] Eur Acad Otol Neurotol. 2017 Jun;38(5):754-8.